Original Source(s)
Related Content
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
Rethinking Menopause Hormone Therapy
A JAMA Perspective outlines how updated FDA labeling may reshape menopause care.
by Kerri Miller
April 23, 2026
-
3 min
Why Is Vaginal Estrogen Still Underused?
A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.
July 6, 2026
-
6 min